CT ATLANTIC
CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies – HD-MABs™ as novel therapeutics for the treatment of cancer. CT Atlantic is a spin-off of the University of Zurich (Zurich, Switzerland) and the Ludwig Institute for Cancer Research (LICR) (Zurich, Switzerland and New York, USA) and has a strong focus on clinical research and applications in the field of oncology. It was founded by Prof. Alexander Knuth, Chairman of the ... Department of Clinical Oncology at the University of Zurich and one of the pioneers in cancer immunotherapy. He was previously Professor for Oncology at the Klinikum Nordwest (Frankfurt, Germany) and University of Frankfurt, Germany. Prior to this he led the clinical trials and research activities in the Ludwig Institute for Cancer Research, New York and its affiliate in the Krankenhaus Nordwest. The Company has entered into worldwide exclusive licensing agreements and performs collaborative research with both the University of Zurich and the LICR. In addition, it has built a network of clinicians and clinical institutions that are closely allied with the Ludwig Institute for Cancer Research, the University of Zurich and Krankenhaus Nordwest (Frankfurt, Germany). The company is currently based in Zurich-Schlieren, Switzerland.
CT ATLANTIC
Social Links:
Industry:
Apps Biotechnology
Founded:
2008-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.ct-atlantic.com
Total Employee:
1+
Status:
Closed
Contact:
+41 44 731 94 00
Email Addresses:
[email protected]
Total Funding:
8.97 M USD
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Founder
Investors List
HS LifeSciences
HS LifeSciences investment in Series A - CT Atlantic
More informations about "CT Atlantic"
CT Atlantic AG - VentureRadar
" CT Atlantic AG is a Swiss biotech company focusing on the research and development of novel, human-derived antibodies for the treatment of cancer. Through the selection of the correct …See details»
CT Atlantic | EquityNet
CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies HD-MABs as novel therapeutics for the treatment of cancer. …See details»
ct atlantic Ltd. - startup.ch
Ct atlantic Ltd.: CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies – HD-MABsâ„¢ as novel therapeutics for …See details»
CT Atlantic - Funding, Financials, Valuation & Investors - Crunchbase
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer. New. Resources. Advanced Search. Start Free Trial . …See details»
CT Atlantic Company Profile: Valuation, Funding
Jan 12, 2009 CT Atlantic General Information Description. Provider of drugs designed to provide treatment of cancer. The company's drugs are use to treat cancer using antibodies derived from cohorts of patients, enabling patients to …See details»
CT Atlantic | Company | RadialReport
CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies – HD-MABsâ„¢ as novel therapeutics for the treatment of …See details»
CT Atlantic - Headquarter Location, Corporate Office Address and ...
CT Atlantic is Biotechnology in Switzerland that focus on provider business. Founded in 2008. They cover business area such as provider, drug, treatment, cancer, use, antibody, cohort, …See details»
CT Atlantic Overview | SignalHire Company Profile
CT Atlantic is a biotechnology company based out of 6Seehofstrasse, Zurich, Zurich, Switzerland. Organization Website. ct-atlantic.com . Social Links. Phone Number +41 44 731 94 00. CT …See details»
CT Atlantic - Products, Competitors, Financials, Employees ...
CT Atlantic is an early stage company focused on the identification and development of human oncology. Use the CB Insights Platform to explore CT Atlantic's full profile. CT Atlantic - …See details»
CT Atlantic AG - VentureRadar
CT Atlantic AG is a Swiss biotech company focusing on the research and development of novel, human-derived antibodies for the treatment of cancer. Through the selection of the correct …See details»
CT ATLANTIC LLC :: Massachusetts (US) - OpenCorporates
Free and open company data on Massachusetts (US) company CT ATLANTIC LLC (company number 001511760), 127 HANSON ROAD, NEWTON, MA, 02459 Changes to our website — …See details»
CT Atlantic - Crunchbase
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer. Search Crunchbase. Start Free Trial . Chrome …See details»
CT Atlantic Ltd.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 28, 2023 Explore CT Atlantic Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Research programme: CT antigen antibodies - CT Atlantic
CT Atlantic is developing patient-derived specific antibodies against CT antigens for the treatment of cancer. The company is using its proprietary BCDTechâ„¢ ... If your organization has a …See details»
CT Atlantic Ltd. | 044 731 94 00 | Schlieren - AllBiz
Sie können CT Atlantic Ltd. unter der Telefonnummer 044 731 94 00 kontaktieren. CT Atlantic Ltd. Kontaktinformationen. CT Atlantic Ltd. Wagistrasse 14, 8952 Schlieren, Switzerland …See details»
Booker, Padilla, Reed Introduce Bills to Permanently Protect the ...
Apr 22, 2025 WASHINGTON, D.C. – On Earth Day, U.S. Senators Cory Booker (D-NJ), Alex Padilla (D-CA), and Jack Reed (D-RI) announced a pair of bills to permanently protect the …See details»
Montana restaurants announced as James Beard nominees
Apr 3, 2025 The James Beard Foundation established the awards in 1990 and has bestowed them since 1991, except in 2020 and 2021 when the organization scrapped them as the …See details»
CT Atlantic - Tech Stack, Apps, Patents & Trademarks - Crunchbase
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer. New. Resources. Advanced Search. Start Free Trial . …See details»
A family of Afghan refugees arrived in CT. Here’s what happened.
2 days ago Rahim’s family’s crisis-driven arrival may be a harbinger of how the new reality looks for refugees and Special Immigrant Visa holders like him, as support flounders and …See details»
Christoph Esslinger - CTO @ CT Atlantic - Crunchbase
Primary Organization . CT Atlantic . Location Zürich, Zurich, Switzerland; Regions Europe, Middle East, and Africa (EMEA) Gender Male; LinkedIn ... Number of Current Jobs 2. Christoph …See details»